Terms: = Leukemia AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Diagnosis
65 results:
1. Gene expression profiling on CML patients with Philadelphia translocation.
Alkhatabi H; Aldahlawi S; Hazzazi MS; Alsolami R; Elaimi A; Almashjary MN; Alserihi R; Alkhatabi HA; Alquthami ME; Daous YM; Bahashwan S; Yasin EB; Barefah A; Alsayes F
Eur Rev Med Pharmacol Sci; 2024 Feb; 28(4):1340-1355. PubMed ID: 38436167
[TBL] [Abstract] [Full Text] [Related]
2. Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.
Judd S; Revon-Riviere G; Grover SA; Deyell RJ; Vanan MI; Lewis VA; Pecheux L; Zorzi AP; Goudie C; Santiago R; Tran TH; Abbott LS; Brossard J; Moorehead P; Alvi S; Portwine C; Denburg A; Whitlock JA; Cohen-Gogo S; Morgenstern DA
Cancer Med; 2024 Feb; 13(3):e7033. PubMed ID: 38400668
[TBL] [Abstract] [Full Text] [Related]
3. Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis.
Ren W; Wan H; Own SA; Berglund M; Wang X; Yang M; Li X; Liu D; Ye X; Sonnevi K; Enblad G; Amini RM; Sander B; Wu K; Zhang H; Wahlin BE; Smedby KE; Pan-Hammarström Q
Leukemia; 2024 Mar; 38(3):610-620. PubMed ID: 38158444
[TBL] [Abstract] [Full Text] [Related]
4. Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy.
Karolová J; Kazantsev D; Svatoň M; Tušková L; Forsterová K; Maláriková D; Benešová K; Heizer T; Dolníková A; Klánová M; Winkovska L; Svobodová K; Hojný J; Krkavcová E; Froňková E; Zemanová Z; Trněný M; Klener P
Am J Hematol; 2023 Oct; 98(10):1627-1636. PubMed ID: 37605345
[TBL] [Abstract] [Full Text] [Related]
5. Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma.
Gao F; Liu H; Meng X; Liu J; Wang J; Yu J; Liu X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Golchehre Z; Chavoshzadeh Z; He J; Zhang H; Wang X
Br J Haematol; 2023 Sep; 202(6):1151-1164. PubMed ID: 37455019
[TBL] [Abstract] [Full Text] [Related]
6. Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia.
Sarno J; Domizi P; Liu Y; Merchant M; Pedersen CB; Jedoui D; Jager A; Nolan GP; Gaipa G; Bendall SC; Bava FA; Davis KL
Nat Commun; 2023 May; 14(1):2935. PubMed ID: 37217509
[TBL] [Abstract] [Full Text] [Related]
7.
Zhao J; Liu J; Liu S; Tian S; Yuan H; Li S
Epigenomics; 2023 Mar; 15(6):369-383. PubMed ID: 37212125
[No Abstract] [Full Text] [Related]
8. diagnosis and Treatment of Chronic Lymphocytic leukemia: A Review.
Shadman M
JAMA; 2023 Mar; 329(11):918-932. PubMed ID: 36943212
[TBL] [Abstract] [Full Text] [Related]
9. Alpha fetoprotein promotes polarization of macrophages towards M2-like phenotype and inhibits macrophages to phagocytize hepatoma cells.
Zhang M; Liu K; Zhang Q; Xu J; Liu J; Lin H; Lin B; Zhu M; Li M
Front Immunol; 2023; 14():1081572. PubMed ID: 36911723
[TBL] [Abstract] [Full Text] [Related]
10. The roles and mechanisms of circular RNAs related to mTOR in cancers.
Cao C; Wang Y; Wu X; Li Z; Guo J; Sun W
J Clin Lab Anal; 2022 Dec; 36(12):e24783. PubMed ID: 36426933
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia.
Rosenberg MW; Savage SL; Eide CA; Reister Schultz A; Cook RJ; Press RD; Rempfer C; Eickelberg G; Wilmot B; McWeeney SK; Tyner JW; Druker BJ; Tognon CE
Cold Spring Harb Mol Case Stud; 2022 Oct; 8(6):. PubMed ID: 36307214
[TBL] [Abstract] [Full Text] [Related]
12. The mRNA Expression of
Lak ER; Tamaddon G; Ramzi M; Ranjbaran R; Abedi E; Sharifzadeh S
Cardiovasc Hematol Agents Med Chem; 2023; 21(1):67-76. PubMed ID: 35993473
[TBL] [Abstract] [Full Text] [Related]
13. miRNAs in Lymphocytic Leukaemias-The miRror of Drug Resistance.
Sbirkov Y; Vergov B; Mehterov N; Sarafian V
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563051
[TBL] [Abstract] [Full Text] [Related]
14. Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia.
Bontoux C; Simonin M; Garnier N; Lhermitte L; Touzart A; Andrieu G; Bruneau J; Lengliné E; Plesa A; Boissel N; Baruchel A; Bertrand Y; Molina TJ; Macintyre E; Asnafi V
Mod Pathol; 2022 Sep; 35(9):1227-1235. PubMed ID: 35562412
[TBL] [Abstract] [Full Text] [Related]
15. Metadherin (AEG-1/MTDH/LYRIC) expression: Significance in malignancy and crucial role in colorectal cancer.
Abdel Ghafar MT; Soliman NA
Adv Clin Chem; 2022; 106():235-280. PubMed ID: 35152973
[TBL] [Abstract] [Full Text] [Related]
16. Either IL-7 activation of JAK-STAT or BEZ inhibition of pi3k-AKT-mTOR pathways dominates the single-cell phosphosignature of
Kuzilková D; Bugarin C; Rejlova K; Schulz AR; Mei HE; Paganin M; Biffi A; Biondi A; Kalina T; Gaipa G
Haematologica; 2022 Jun; 107(6):1293-1310. PubMed ID: 34670357
[TBL] [Abstract] [Full Text] [Related]
17. BCL-2 Inhibition as Treatment for Chronic Lymphocytic leukemia.
Perini GF; Feres CCP; Teixeira LLC; Hamerschlak N
Curr Treat Options Oncol; 2021 Jun; 22(8):66. PubMed ID: 34110507
[TBL] [Abstract] [Full Text] [Related]
18. ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/pi3k/AKT signalling pathway by combining with P53.
Li L; Feng Y; Hu S; Du Y; Xu X; Zhang M; Peng X; Chen F
J Cell Mol Med; 2021 Jun; 25(11):5295-5304. PubMed ID: 33960640
[TBL] [Abstract] [Full Text] [Related]
19. Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating pi3k/AKT and ERK signaling pathways.
Jiang H; Tang J; Qiu L; Zhang Z; Shi S; Xue L; Kui L; Huang T; Nan W; Zhou B; Zhao C; Yu M; Sun Q
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649851
[TBL] [Abstract] [Full Text] [Related]
20. Bioinformatics Analysis Identifies Key Genes and Pathways in Acute Myeloid leukemia Associated with DNMT3A Mutation.
Chen S; Chen Y; Lu J; Yuan D; He L; Tan H; Xu L
Biomed Res Int; 2020; 2020():9321630. PubMed ID: 33299888
[TBL] [Abstract] [Full Text] [Related]
[Next]